|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Akums exclusively ties up with Jagdale for manufacturing of Ready-to-Drink nutritional beverages in aseptic carton technology
|
|
Saturday, 07 December, 2024, 14 : 00 PM [IST]
|
|
Our Bureau, New Delhi
|
Akums Drugs & Pharmaceuticals Ltd., India's Largest contract development and manufacturing organisation (CDMO), has announced a partnership with Jagdale Industries Private Ltd., a pioneering name in India’s healthcare sector. This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in carton packing for the ready-to-drink (RTD) market, targeting an expansive array of health and wellness products.
Together, both companies aim to revolutionise the market by introducing innovative, non-milk-based aseptic carton packing solutions across key categories like a) wellness drinks under food, Ayush and nutraceutical frameworks, b) Sports nutrition with essential electrolytes for hydration and recovery c) Nutritional products for critical care, diabetes, and weight management.
Sanjeev Jain, managing director of Akums Drugs & Pharmaceuticals Ltd., said, “India's Ready-to-Drink market is witnessing a significant surge as consumers increasingly prioritise health, convenience, and quality. With this partnership, Akums and Jagdale will deliver products that seamlessly integrate health benefits with superior Aseptic packaging technology. Aseptic packing solutions ensure the highest standards of safety, shelf stability, and nutrient retention, meeting the evolving needs of modern consumers.”
Rajesh N. Jagdale, managing director of Jagdale group, said, “The collaboration represents a strategic convergence of Akums’ strong and extensive clients base and Jagdale’s legacy in healthcare innovation. emphasised the potential impact of this alliance. We are excited to partner with Akums, a name synonymous with trust and quality. Together, we aim to redefine the ready-to-drink segment in India, catering to diverse consumer needs across mass, premium, and medical markets. Our focus on non-milk-based formulations ensures inclusivity and addresses a broad spectrum of dietary preferences and prophylactic requirements.”
|
|
|
|
|
|
|
|
|
|